Global CEO Search for Spine Robotics Pioneer Closed in 12 Weeks, LEM Surgical

LEM Surgical needed a founding CEO with hands-on spinal robotics build experience at an executive level, not someone adjacent to the space, but someone who had done it. That profile existed in only a handful of people globally. The role also required relocation to Bern, Switzerland, which eliminated most candidates before the conversation even started. There was no open talent pool to search, no shortlist to pull from, and no margin for a mis-hire. For early-stage MedTech companies facing a similar situation, whether hiring a founding CEO, a first commercial lead, or a regulatory head with no obvious successor pool, the challenge is the same: the right person is rarely visible, rarely looking, and rarely reachable through conventional channels.

Guided Solutions ran a genuinely global search, mapping leadership across spinal, orthopedic, and soft-tissue robotics. Rather than working from a database of active candidates, the team built a picture of the entire relevant leadership universe and engaged high-caliber passive candidates who were not on the open market. Every approach was made under strict confidentiality, protecting LEM Surgical's competitive position throughout the process. For MedTech startups conducting executive searches in specialist or emerging technology segments, passive candidate engagement is not a nice-to-have. It is the only way to access the people who are actually qualified. The candidates who will move the business forward are almost never the ones applying. They are the ones who need to be found, approached with credibility, and given a compelling reason to listen.

The search closed in 12 weeks with the appointment of Yossi Bar as founding CEO. Yossi had recently exited Mazor Robotics, the company that defined the spine robotics category before its acquisition by Medtronic, bringing exactly the build experience the brief required. He relocated to Switzerland and LEM Surgical was stood up around the appointment. The company later closed an oversubscribed CHF 22M Series B from Swiss and US investors, and the Dynamis Robotic Surgical System has since received US FDA clearance.
 

For MedTech founders and investors evaluating executive search for early-stage leadership hires, the LEM Surgical case illustrates the compounding value of getting the first appointment right. The right founding CEO does not just fill a seat. They attract capital, build credibility with investors, and create the conditions for everything that follows.